Holla ØL - Search Results

1

Genetic overlap between ALS and other neurodegenerative or neuromuscular disorders.

Olsen CG, Busk ØL, Holla ØL, Tveten K, Holmøy T, Tysnes OB, Høyer H. Olsen CG, et al. Among authors: holla ol. Amyotroph Lateral Scler Frontotemporal Degener. 2024 Feb;25(1-2):177-187. doi: 10.1080/21678421.2023.2270705. Epub 2024 Jan 23. Amyotroph Lateral Scler Frontotemporal Degener. 2024. PMID: 37849306

2

Genome-wide expression analysis of cells expressing gain of function mutant D374Y-PCSK9.

Ranheim T, Mattingsdal M, Lindvall JM, Holla OL, Berge KE, Kulseth MA, Leren TP. Ranheim T, et al. Among authors: holla ol. J Cell Physiol. 2008 Nov;217(2):459-67. doi: 10.1002/jcp.21519. J Cell Physiol. 2008. PMID: 18570182

3

A pregnant woman with pancytopenia.

Jensvoll H, Smeland MF, Tiller H, Holla ØL, Prescott TE, Vik A. Jensvoll H, et al. Among authors: holla ol. Tidsskr Nor Laegeforen. 2019 Nov 18;139(17). doi: 10.4045/tidsskr.19.0022. Print 2019 Nov 19. Tidsskr Nor Laegeforen. 2019. PMID: 31746163 Free article. English, Norwegian. No abstract available.

4

4-Phenylbutyrate restores the functionality of a misfolded mutant low-density lipoprotein receptor.

Tveten K, Holla ØL, Ranheim T, Berge KE, Leren TP, Kulseth MA. Tveten K, et al. Among authors: holla ol. FEBS J. 2007 Apr;274(8):1881-93. doi: 10.1111/j.1742-4658.2007.05735.x. Epub 2007 Mar 5. FEBS J. 2007. PMID: 17408384 Free article.

5

Disrupted recycling of the low density lipoprotein receptor by PCSK9 is not mediated by residues of the cytoplasmic domain.

Strøm TB, Holla ØL, Tveten K, Cameron J, Berge KE, Leren TP. Strøm TB, et al. Among authors: holla ol. Mol Genet Metab. 2010 Sep;101(1):76-80. doi: 10.1016/j.ymgme.2010.05.003. Epub 2010 Jun 9. Mol Genet Metab. 2010. PMID: 20659812

6

Removal of acidic residues of the prodomain of PCSK9 increases its activity towards the LDL receptor.

Holla ØL, Laerdahl JK, Strøm TB, Tveten K, Cameron J, Berge KE, Leren TP. Holla ØL, et al. Biochem Biophys Res Commun. 2011 Mar 11;406(2):234-8. doi: 10.1016/j.bbrc.2011.02.023. Epub 2011 Feb 13. Biochem Biophys Res Commun. 2011. PMID: 21324305

7

The cytoplasmic domain is not involved in directing Class 5 mutant LDL receptors to lysosomal degradation.

Strøm TB, Tveten K, Holla ØL, Cameron J, Berge KE, Leren TP. Strøm TB, et al. Among authors: holla ol. Biochem Biophys Res Commun. 2011 May 20;408(4):642-6. doi: 10.1016/j.bbrc.2011.04.077. Epub 2011 Apr 21. Biochem Biophys Res Commun. 2011. PMID: 21531209

8

Role of the C-terminal domain of PCSK9 in degradation of the LDL receptors.

Holla ØL, Cameron J, Tveten K, Strøm TB, Berge KE, Laerdahl JK, Leren TP. Holla ØL, et al. J Lipid Res. 2011 Oct;52(10):1787-94. doi: 10.1194/jlr.M018093. Epub 2011 Jul 19. J Lipid Res. 2011. PMID: 21771976 Free PMC article.

9

Characterization of a naturally occurring degradation product of the LDL receptor.

Tveten K, Strøm TB, Cameron J, Holla ØL, Berge KE, Leren TP. Tveten K, et al. Among authors: holla ol. Mol Genet Metab. 2012 Jan;105(1):149-54. doi: 10.1016/j.ymgme.2011.10.008. Epub 2011 Oct 24. Mol Genet Metab. 2012. PMID: 22078455

10

Characterization of residues in the cytoplasmic domain of the LDL receptor required for exit from the endoplasmic reticulum.

Strøm TB, Tveten K, Holla ØL, Cameron J, Berge KE, Leren TP. Strøm TB, et al. Among authors: holla ol. Biochem Biophys Res Commun. 2011 Dec 2;415(4):642-5. doi: 10.1016/j.bbrc.2011.10.127. Epub 2011 Nov 2. Biochem Biophys Res Commun. 2011. PMID: 22079632

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page